'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
Judith I TsuiMichael P BarryElizabeth J AustinElsa W SweekElyse TungRyan N HansenMichael NinburgJohn D ScottSara N GlickEmily C WilliamsPublished in: Addiction science & clinical practice (2021)
Even in the direct-acting antivirals era, people who inject drugs still face major barriers to hepatitis C treatment which may be reduced by providing low-barrier points of access for care through pharmacists. Key recommendations for community-pharmacy design included providing care team training to reduce stigma and ensuring care team structures and culture target PWID-specific needs for education and engagement.